S&P 500 7,509 -0.46% Nasdaq 25,837 -1.03% Dow Jones 52,225 -0.54% FTSE 100 10,585 +0.66% DAX 25,000 +0.00% Nikkei 225 66,116 -3.83% Hang Seng 24,857 +0.71% WTI Crude 87.62 +6.22% Gold 4,116 +2.56% US 10-Year Treasury Yield 4.628 +1.83% S&P 500 7,509 -0.46% Nasdaq 25,837 -1.03% Dow Jones 52,225 -0.54% FTSE 100 10,585 +0.66% DAX 25,000 +0.00% Nikkei 225 66,116 -3.83% Hang Seng 24,857 +0.71% WTI Crude 87.62 +6.22% Gold 4,116 +2.56% US 10-Year Treasury Yield 4.628 +1.83%

LATEST

David Vélez OpenAI Board Role Signals Nubank AI Push●Brazil Holds Fire as US Tariff Takes Effect●Uruguay Peso Bonds See 4x Demand in July Auction●Peru Infrastructure Corridor: $15.6B Committed vs. Vision●BIS warns USD stablecoins can evade capital controls, challenging traditional market regulations●US seeks forfeiture of $25 million in crypto tied to global fraud investigations●Gold, Silver Outlook: Investors cautious on gold, silver in no trade zone - Key levels to watch●Bharat Coking Coal share price crashes 7% after Q1FY27 results●David Vélez OpenAI Board Role Signals Nubank AI Push●Brazil Holds Fire as US Tariff Takes Effect●Uruguay Peso Bonds See 4x Demand in July Auction●Peru Infrastructure Corridor: $15.6B Committed vs. Vision●BIS warns USD stablecoins can evade capital controls, challenging traditional market regulations●US seeks forfeiture of $25 million in crypto tied to global fraud investigations●Gold, Silver Outlook: Investors cautious on gold, silver in no trade zone - Key levels to watch●Bharat Coking Coal share price crashes 7% after Q1FY27 results●

Asia

MedPlus Health shares tumble 16% after Q1 profit falls 21% YoY. Should you buy, sell or hold?

Markets-Economic Times · 2h ago · 🇮🇳 India

MedPlus Health shares tumble 16% after Q1 profit falls 21% YoY. Should you buy, sell or hold?

MedPlus Health Services shares tumbled after the company reported a weaker-than-expected Q1FY27. Despite healthy 21.9% revenue growth to ₹1,880 crore, investors were disappointed by the profitability miss. Brokerage Nomura maintained its 'Buy' rating, highlighting MedPlus' long-term growth potential driven by its store expansion strategy.

Read the full story at Markets-Economic Times →

More Asia

Gold, Silver Outlook: Investors cautious on gold, silver in no trade zone - Key levels to watch

mint - markets · 26m ago

Bharat Coking Coal share price crashes 7% after Q1FY27 results

mint - markets · 28m ago

BYD’s challenge to Porsche; why Chinese cars are struggling locally: 7 EV reads

Business - South China Morning Post · 33m ago

Strong Q1 aside, Paytm needs AI revenue to unlock further upside

mint - markets · 34m ago